Pluri Inc. Payments for Repurchase of Private Placement
Pluri Inc. (PLUR) reported Payments for Repurchase of Private Placement of $5.80 million for the 6-month period ending 2022-12-31, per its 10-Q filed 2023-02-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfPrivatePlacement · last filed 2023-02-13
- 2022-12-31: Payments for Repurchase of Private Placement 6 month $5.80M.
| Period end | Payments for Repurchase of Private Placement 6 month |
|---|---|
| 2022-12-31 | $5.80M 10-Q · filed 2023-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |